{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:22Z","timestamp":1790803642634,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Intensive Medicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jointm.2022.05.001","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T16:26:09Z","timestamp":1655051169000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Alternatives to norepinephrine in septic shock: Which agents and when?"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-4065","authenticated-orcid":false,"given":"Mathieu","family":"Jozwiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0001","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0002","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00134-019-05801-z","article-title":"Vasopressor therapy in critically ill patients with shock","volume":"45","author":"Russell","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jointm.2022.05.001_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcrc.2021.11.015","article-title":"Adherence to surviving sepsis campaign guidelines 2016 regarding fluid resuscitation and vasopressors in the initial management of septic shock: the emerging part of the iceberg!","volume":"68","author":"Jozwiak","year":"2022","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0004","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13613-019-0498-7","article-title":"Current use of vasopressors in septic shock","volume":"9","author":"Scheeren","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0005","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/cc9207","article-title":"Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension","volume":"14","author":"Hamzaoui","year":"2010","journal-title":"Crit Care"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0006","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CCM.0b013e318206d2a3","article-title":"Norepinephrine increases cardiac preload and reduces preload dependency assessed by passive leg raising in septic shock patients","volume":"39","author":"Monnet","year":"2011","journal-title":"Crit Care Med"},{"issue":"12","key":"10.1016\/j.jointm.2022.05.001_bib0007","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1097\/CCM.0b013e318260c6c3","article-title":"Effects of norepinephrine on mean systemic pressure and venous return in human septic shock","volume":"40","author":"Persichini","year":"2012","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0008","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","article-title":"Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock","volume":"25","author":"Adda","year":"2021","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0009","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bja.2017.11.065","article-title":"Norepinephrine exerts an inotropic effect during the early phase of human septic shock","volume":"120","author":"Hamzaoui","year":"2018","journal-title":"Br J Anaesthesia"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.202102-0442LE","article-title":"Change in myocardial contractility in response to treatment with norepinephrine in septic shock","volume":"204","author":"Innocenti","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0011","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00134-010-2013-3","article-title":"Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients","volume":"36","author":"Georger","year":"2010","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1164\/rccm.200109-016OC","article-title":"Microvascular blood flow is altered in patients with sepsis","volume":"166","author":"De Backer","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jointm.2022.05.001_bib0013","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00134-017-4909-7","article-title":"Intensive care medicine in 2050: vasopressors in sepsis","volume":"44","author":"Teboul","year":"2018","journal-title":"Intensive Care Med"},{"issue":"17","key":"10.1016\/j.jointm.2022.05.001_bib0014","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SHK.0000000000001726","article-title":"A randomized porcine study in low cardiac output of vasoactive and inotropic drug effects on the gastrointestinal tract","volume":"56","author":"Seilitz","year":"2021","journal-title":"Shock"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0016","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13613-018-0449-8","article-title":"Hemodynamic support in the early phase of septic shock: a review of challenges and unanswered questions","volume":"8","author":"Lesur","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0017","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1164\/rccm.201604-0862CP","article-title":"Potentially inadvertent immunomodulation: norepinephrine use in sepsis","volume":"194","author":"Stolk","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0018","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1164\/rccm.202002-0339OC","article-title":"Norepinephrine dysregulates the immune response and compromises host defense during sepsis","volume":"202","author":"Stolk","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jointm.2022.05.001_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000005503","article-title":"The \u03b21-adrenergic receptor contributes to sepsis-induced immunosuppression through modulation of regulatory t-cell inhibitory function","author":"Durand","year":"2022","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/cc10245","article-title":"Clinical review: thinking outside the box \u2013 an iconoclastic view of current practice","volume":"15","author":"Singer","year":"2011","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0021","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/CCM.0000000000001441","article-title":"Selepressin in septic shock: a step toward decatecholaminization?","volume":"44","author":"Asfar","year":"2016","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0022","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00134-021-06595-9","article-title":"Current practice and evolving concepts in septic shock resuscitation","volume":"48","author":"Bakker","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jointm.2022.05.001_bib0023","first-page":"271","article-title":"Peripheral vascular and other effects of dopamine infusions in man","volume":"27","author":"Allwood","year":"1964","journal-title":"Clin Sci (Colch)"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0024","first-page":"S11","article-title":"The use of low doses of dopamine in intensive care medicine","volume":"92","author":"D'Orio","year":"1984","journal-title":"Arch Physiol Biochem"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-0040-1710320","article-title":"Vasopressor therapy in the intensive care unit","volume":"42","author":"Russell","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0026","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jointm.2022.05.001_bib0027","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"issue":"9588","key":"10.1016\/j.jointm.2022.05.001_bib0028","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0140-6736(07)61344-0","article-title":"Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial","volume":"370","author":"Annane","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0029","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1060028019843664","article-title":"Norepinephrine and vasopressin compared with norepinephrine and epinephrine in adults with septic shock","volume":"53","author":"Menich","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0030","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s001340050329","article-title":"Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study","volume":"23","author":"Levy","year":"1997","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0031","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00134-002-1611-0","article-title":"Effects of epinephrine and norepinephrine on hemodynamics, oxidative metabolism, and organ energetics in endotoxemic rats","volume":"29","author":"Levy","year":"2003","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0032","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/SHK.0b013e318167378f","article-title":"Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states","volume":"30","author":"Levy","year":"2008","journal-title":"Shock"},{"issue":"9462","key":"10.1016\/j.jointm.2022.05.001_bib0033","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(05)71045-X","article-title":"Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study","volume":"365","author":"Levy","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0034","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/01.CCM.0000215834.48023.57","article-title":"Effects of epinephrine, norepinephrine, and phenylephrine on microcirculatory blood flow in the gastrointestinal tract in sepsis","volume":"34","author":"Krejci","year":"2006","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0035","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/01.CCM.0000063045.77339.B6","article-title":"Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best?","volume":"31","author":"De Backer","year":"2003","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0036","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/00003246-199710000-00013","article-title":"Dobutamine improves the adequacy of gastric mucosal perfusion in epinephrine-treated septic shock","volume":"25","author":"Levy","year":"1997","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jointm.2022.05.001_bib0037","first-page":"654","article-title":"Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock","volume":"23","author":"Zhou","year":"2002","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0038","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00003246-199905000-00021","article-title":"Effects of epinephrine, norepinephrine, or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock","volume":"27","author":"Duranteau","year":"1999","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13613-020-0628-2","article-title":"Vasopressin and its analogues in shock states: a review","volume":"10","author":"Demiselle","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.CCM.0000251127.45385.CD","article-title":"Vasopressin: mechanisms of action on the vasculature in health and in septic shock","volume":"35","author":"Barrett","year":"2007","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0041","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1124\/jpet.111.178848","article-title":"Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension","volume":"337","author":"Laporte","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0042","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-198007000-00004","article-title":"Greatly enhanced pressor response to antidiuretic hormone in patients with impaired cardiovascular reflexes due to idiopathic orthostatic hypotension","volume":"2","author":"M\u00f6hring","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0043","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-8703(41)90649-X","article-title":"Circulatory effects following the intravenous administration of pitressin in normal persons and in patients with hypertension and angina pectoris","volume":"21","author":"Graybiel","year":"1941","journal-title":"Am Heart J"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0044","first-page":"869","article-title":"Vasopressin release during sepsis and septic shock in baboons and dogs","volume":"153","author":"Wilson","year":"1981","journal-title":"Surg Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0045","first-page":"H1228","article-title":"Effects of vasopressin on pulmonary and systemic vascular mechanics","volume":"257","author":"Wallace","year":"1989","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0046","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1378\/chest.103.4.1241","article-title":"Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide","volume":"103","author":"Evora","year":"1993","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0047","first-page":"E566","article-title":"Vasopressin: a regulator of adrenal glucocorticoid production","volume":"256","author":"Brooks","year":"1989","journal-title":"Am J Physiol"},{"issue":"1\u20132","key":"10.1016\/j.jointm.2022.05.001_bib0048","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","article-title":"Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation","volume":"96","author":"Aguilera","year":"2000","journal-title":"Regul Pept"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0049","doi-asserted-by":"crossref","first-page":"R979","DOI":"10.1152\/ajpregu.00520.2001","article-title":"Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats","volume":"282","author":"Bucher","year":"2002","journal-title":"Am J Physiol-Regul, Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.shk.0000235140.97903.90","article-title":"Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia","volume":"27","author":"Ertmer","year":"2007","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.001_bib0051","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1097\/CCM.0b013e318180b51d","article-title":"Role of nuclear factor-kappaB-dependent induction of cytokines in the regulation of vasopressin V1A-receptors during cecal ligation and puncture-induced circulatory failure","volume":"36","author":"Schmidt","year":"2008","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0052","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","article-title":"The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial","volume":"42","author":"Gordon","year":"2014","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0053","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/CCM.0000000000000262","article-title":"Steroids and vasopressin in septic shock-brother and sister or just distant cousins","volume":"42","author":"Asfar","year":"2014","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0054","first-page":"H663","article-title":"Cardiac output distribution during vasopressin infusion or dehydration in conscious dogs","volume":"243","author":"Liard","year":"1982","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0055","first-page":"273","article-title":"Evaluation of cardiac output, total peripheral vascular resistance, and plasma concentrations of vasopressin in the conscious, unrestrained rat during endotoxemia","volume":"17","author":"Brackett","year":"1985","journal-title":"Circ Shock"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0056","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1097\/01.CCM.0000063046.82359.4A","article-title":"Circulating vasopressin levels in septic shock","volume":"31","author":"Sharshar","year":"2003","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0057","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","article-title":"Vasopressin deficiency contributes to the vasodilation of septic shock","volume":"95","author":"Landry","year":"1997","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0058","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00003246-200203000-00001","article-title":"Depletion of neurohypophyseal content of vasopressin in septic shock","volume":"30","author":"Sharshar","year":"2002","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0059","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1164\/ajrccm.160.2.9810073","article-title":"Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach","volume":"160","author":"Annane","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF01819137","article-title":"Spectral analysis of heart rate variability in the sepsis syndrome","volume":"3","author":"Garrard","year":"1993","journal-title":"Clin Auton Res"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0061","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1097\/CCM.0b013e3181eb9acf","article-title":"Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock","volume":"38","author":"Siami","year":"2010","journal-title":"Crit Care Med"},{"issue":"9398","key":"10.1016\/j.jointm.2022.05.001_bib0062","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(03)14899-4","article-title":"Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock","volume":"362","author":"Sharshar","year":"2003","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0063","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1750-3639.2009.00355.x","article-title":"Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock","volume":"20","author":"Sonneville","year":"2010","journal-title":"Brain Pathol"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0064","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00005373-199910000-00014","article-title":"Low-dose vasopressin in the treatment of vasodilatory septic shock","volume":"47","author":"Malay","year":"1999","journal-title":"J Trauma"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0065","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","article-title":"Beneficial effects of short-term vasopressin infusion during severe septic shock","volume":"96","author":"Patel","year":"2002","journal-title":"Anesthesiology"},{"issue":"18","key":"10.1016\/j.jointm.2022.05.001_bib0066","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","article-title":"Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study","volume":"107","author":"D\u00fcnser","year":"2003","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0067","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1097\/01.CCM.0000186749.34028.40","article-title":"Arginine vasopressin in 316 patients with advanced vasodilatory shock","volume":"33","author":"Luckner","year":"2005","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0068","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0069","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/CCM.0000000000002323","article-title":"The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience","volume":"45","author":"Russell","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00134-009-1687-x","article-title":"The effects of vasopressin on acute kidney injury in septic shock","volume":"36","author":"Gordon","year":"2010","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0071","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","article-title":"Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock","volume":"37","author":"Russell","year":"2009","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0072","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0073","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00134-019-05620-2","article-title":"Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials","volume":"45","author":"Nagendran","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0074","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-019-2362-4","article-title":"The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis","volume":"23","author":"Jiang","year":"2019","journal-title":"Crit Care"},{"issue":"18","key":"10.1016\/j.jointm.2022.05.001_bib0075","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0076","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/SHK.0000000000001345","article-title":"Norepinephrine vs vasopressin: which vasopressor should be discontinued first in septic shock? A meta-analysis","volume":"53","author":"Wu","year":"2020","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0077","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00134-018-5267-9","article-title":"Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial","volume":"44","author":"Liu","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jointm.2022.05.001_bib0078","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3389\/fphar.2019.01492","article-title":"Terlipressin versus norepinephrine for septic shock: a systematic review and meta-analysis","volume":"10","author":"Huang","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jointm.2022.05.001_bib0079","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fphar.2020.00563","article-title":"Clinical efficiency of vasopressin or its analogs in comparison with catecholamines alone on patients with septic shock: a systematic review and meta-analysis","volume":"11","author":"Yao","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0080","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/CCM.0000000000001380","article-title":"A selective V(1A) receptor agonist, selepressin, is superior to arginine vasopressin and to norepinephrine in ovine septic shock","volume":"44","author":"He","year":"2016","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jointm.2022.05.001_bib0081","doi-asserted-by":"crossref","first-page":"e525","DOI":"10.1097\/CCM.0000000000000300","article-title":"The selective vasopressin type 1a receptor agonist selepressin (FE 202158) blocks vascular leak in ovine severe sepsis*","volume":"42","author":"Maybauer","year":"2014","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0082","doi-asserted-by":"crossref","first-page":"H1245","DOI":"10.1152\/ajpheart.00390.2012","article-title":"Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis","volume":"303","author":"Rehberg","year":"2012","journal-title":"Am J Physiol-Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0083","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CCM.0b013e3181fa3898","article-title":"Role of selective V1a receptor agonism in ovine septic shock","volume":"39","author":"Rehberg","year":"2011","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0084","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1124\/jpet.120.000146","article-title":"Protective mechanism of the selective vasopressin V1A receptor agonist selepressin against endothelial barrier dysfunction","volume":"375","author":"Barabutis","year":"2020","journal-title":"J Pharmacol Exp Therap"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0085","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-017-1798-7","article-title":"Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase \u2161a randomized, placebo-controlled trial in septic shock patients","volume":"21","author":"Russell","year":"2017","journal-title":"Crit Care"},{"issue":"15","key":"10.1016\/j.jointm.2022.05.001_bib0086","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/jama.2019.14607","article-title":"Effect of selepressin vs placebo on ventilator- and vasopressor-free days in patients with septic shock: the SEPSIS-ACT randomized clinical trial","volume":"322","author":"Laterre","year":"2019","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jointm.2022.05.001_bib0087","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3390\/cells10071767","article-title":"Renin-angiotensin-aldosterone system and immunomodulation: a state-of-the-art review","volume":"10","author":"Laghlam","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0088","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XX\u2161I. The angiotensin \u2161 receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol Rev"},{"issue":"8\u20139","key":"10.1016\/j.jointm.2022.05.001_bib0089","first-page":"1493","article-title":"Renin-angiotensin system in sepsis","volume":"9","author":"Hilgenfeldt","year":"1987","journal-title":"Clin Exp Hypertens A"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0272-6386(88)80170-7","article-title":"Vasoactive hormones in the renal response to systemic sepsis","volume":"11","author":"Cumming","year":"1988","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0091","first-page":"144","article-title":"Role of angiotensin \u2161 in neonatal sepsis","volume":"40","author":"Dunn","year":"1993","journal-title":"Circ Shock"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0092","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0025-7125(16)30093-1","article-title":"The endocrine response to critical illness","volume":"79","author":"Rolih","year":"1995","journal-title":"Med Clin North Am"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0093","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1097\/00003246-199810000-00018","article-title":"Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill","volume":"26","author":"Boldt","year":"1998","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0094","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1365-201x.1999.00574.x","article-title":"Differentiation of the peptidergic vasoregulatory response to standardized splanchnic hypoperfusion by acute hypovolaemia or sepsis in anaesthetized pigs","volume":"166","author":"Aneman","year":"1999","journal-title":"Acta Physiol Scand"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.38.2.177","article-title":"Downregulation of angiotensin \u2161 type 1 receptors during sepsis","volume":"38","author":"Bucher","year":"2001","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0096","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","article-title":"Hyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failure","volume":"29","author":"du Cheyron","year":"2003","journal-title":"Intensive Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0097","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJMra032401","article-title":"Acute renal failure and sepsis","volume":"351","author":"Schrier","year":"2004","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0098","doi-asserted-by":"crossref","first-page":"R328","DOI":"10.1186\/cc2902","article-title":"Erythropoietin and renin as biological markers in critically ill patients","volume":"8","author":"Tamion","year":"2004","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0099","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/hy1201.101214","article-title":"History about the discovery of the renin-angiotensin system","volume":"38","author":"Basso","year":"2001","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0100","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/01.CCM.0000124875.98492.11","article-title":"Pulmonary injury follows systemic inflammatory reaction in infrarenal aortic surgery","volume":"32","author":"Adembri","year":"2004","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3317\/jraas.2007.003","article-title":"Novel roles of intracrine angiotensin \u2161 and signalling mechanisms in kidney cells","volume":"8","author":"Zhuo","year":"2007","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"11","key":"10.1016\/j.jointm.2022.05.001_bib0102","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00003246-198811000-00010","article-title":"Association between renal and sympathetic responses to nonhypotensive systemic sepsis","volume":"16","author":"Cumming","year":"1988","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0103","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0001-5172.2004.00283.x","article-title":"The angiotensin \u2161 receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model","volume":"48","author":"Laesser","year":"2004","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/SHK.0b013e31815dd780","article-title":"Low-dose candesartan improves renal blood flow and kidney oxygen tension in rats with endotoxin-induced acute kidney dysfunction","volume":"30","author":"Nitescu","year":"2008","journal-title":"Shock"},{"issue":"3988","key":"10.1016\/j.jointm.2022.05.001_bib0105","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.172.3988.1138","article-title":"Angiotensin \u2161: rapid localization in nuclei of smooth and cardiac muscle","volume":"172","author":"Robertson","year":"1971","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0106","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0006-8993(77)90296-7","article-title":"Distribution of angiotensin \u2161 receptors in rat brain","volume":"122","author":"Sirett","year":"1977","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.jointm.2022.05.001_bib0107","first-page":"E439","article-title":"Presence of renin within intramitochondrial dense bodies of the rat adrenal cortex","volume":"271","author":"Peters","year":"1996","journal-title":"Am J Physiol"},{"issue":"9A","key":"10.1016\/j.jointm.2022.05.001_bib0108","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/j.1582-4934.2008.00448.x","article-title":"Cytosolic renin is targeted to mitochondria and induces apoptosis in H9c2 rat cardiomyoblasts","volume":"13","author":"Wanka","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0109","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/01.hjh.0000226182.60321.69","article-title":"Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review","volume":"24","author":"Duprez","year":"2006","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0110","doi-asserted-by":"crossref","first-page":"H3726","DOI":"10.1152\/ajpheart.01116.2007","article-title":"Role of angiotensin \u2161 in endothelial dysfunction induced by lipopolysaccharide in mice","volume":"293","author":"Lund","year":"2007","journal-title":"Am J Physiol-Heart Circul Physiol"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0111","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13613-019-0536-5","article-title":"Sensitivity to angiotensin \u2161 dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial","volume":"9","author":"Ham","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0112","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","article-title":"Nitric oxide-dependent down-regulation of angiotensin \u2161 type 2 receptors during experimental sepsis","volume":"29","author":"Bucher","year":"2001","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0113","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin \u2161 for the treatment of high-output shock (ATHOS trial): a pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0114","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin \u2161 for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13054-018-2202-y","article-title":"Angiotensin converting enzyme defects in shock: implications for future therapy","volume":"22","author":"Chawla","year":"2018","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0116","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3892\/etm.2014.1566","article-title":"Severe sepsis: low expression of the renin-angiotensin system is associated with poor prognosis","volume":"7","author":"Zhang","year":"2014","journal-title":"Exp Therap Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0117","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13054-016-1306-5","article-title":"The use of angiotensin \u2161 in distributive shock","volume":"20","author":"Chawla","year":"2016","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0118","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1373\/jalm.2018.027995","article-title":"Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples","volume":"3","author":"Rehfeld","year":"2019","journal-title":"J Appl Lab Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0119","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/joim.13220","article-title":"Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3","volume":"289","author":"van Lier","year":"2021","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-021-03471-2","article-title":"Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational study","volume":"25","author":"Blet","year":"2021","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.001_bib0121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238039","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 restores cardiac function in a sepsis-induced model in rats: a proof of concept study","volume":"15","author":"Deniau","year":"2020","journal-title":"PLoS One"},{"issue":"8990","key":"10.1016\/j.jointm.2022.05.001_bib0122","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(95)91933-3","article-title":"Severe septic shock unresponsive to noradrenaline","volume":"346","author":"Wray","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0123","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin \u2161 in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0124","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00134-012-2487-2","article-title":"Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin \u2161 infusion","volume":"38","author":"May","year":"2012","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.001_bib0125","doi-asserted-by":"crossref","first-page":"e550","DOI":"10.1097\/CCM.0000000000000397","article-title":"Angiotensin \u2161 in septic shock: effects on tissue perfusion, organ function, and mitochondrial respiration in a porcine model of fecal peritonitis","volume":"42","author":"Corr\u00eaa","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jointm.2022.05.001_bib0126","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jama.1961.03040490020005","article-title":"Clinical experience with angiotensin \u2161 in the treatment of shock","volume":"178","author":"Del Greco","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.jointm.2022.05.001_bib0127","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.CIR.25.1.263","article-title":"Adjunctive use of a biologic pressor agent, angiotensin, in management of shock","volume":"25","author":"Derrick","year":"1962","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jointm.2022.05.001_bib0128","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/SHK.0000000000000807","article-title":"Angiotensin \u2161 in refractory septic shock","volume":"47","author":"Antonucci","year":"2017","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.001_bib0129","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/00003246-199108000-00020","article-title":"Administration of angiotensin \u2161 in refractory septic shock","volume":"19","author":"Thomas","year":"1991","journal-title":"Crit Care Med"},{"issue":"4","key":"10.1016\/j.jointm.2022.05.001_bib0130","first-page":"277","article-title":"Vasodilatory shock in the ICU and the role of angiotensin \u2161","volume":"24","author":"Wakefield","year":"2018","journal-title":"Curr Opin Crit Care"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0131","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin \u2161 for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0132","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin \u2161","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0133","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-015-0802-3","article-title":"Angiotensin \u2161 in septic shock","volume":"19","author":"Corr\u00eaa","year":"2015","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.jointm.2022.05.001_bib0134","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13054-018-1995-z","article-title":"Angiotensin in critical care","volume":"22","author":"Hall","year":"2018","journal-title":"Crit Care"},{"issue":"8","key":"10.1016\/j.jointm.2022.05.001_bib0135","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin \u2161 administration: a systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit Care Med"},{"issue":"10","key":"10.1016\/j.jointm.2022.05.001_bib0136","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.jointm.2022.05.001_bib0137","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0310057X0203000606","article-title":"The influence of methylene blue infusion on cytokine levels during severe sepsis","volume":"30","author":"Memis","year":"2002","journal-title":"Anaesth Intensive Care"},{"issue":"9","key":"10.1016\/j.jointm.2022.05.001_bib0138","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1007\/s12325-020-01422-x","article-title":"Vasopressor-sparing action of methylene blue in severe sepsis and shock: a narrative review","volume":"37","author":"Puntillo","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.jointm.2022.05.001_bib0139","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jcrc.2020.02.011","article-title":"Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock","volume":"57","author":"Tchen","year":"2020","journal-title":"J Crit Care"},{"issue":"2","key":"10.1016\/j.jointm.2022.05.001_bib0140","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chest.2019.08.2211","article-title":"Broad spectrum vasopressors support sparing strategies in vasodilatory shock beyond the vascular receptors","volume":"157","author":"Evora","year":"2020","journal-title":"Chest"}],"container-title":["Journal of Intensive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667100X22000469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:02:16Z","timestamp":1763024536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667100X22000469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":140,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2667100X22000469"],"URL":"https:\/\/doi.org\/10.1016\/j.jointm.2022.05.001","relation":{},"ISSN":["2667-100X"],"issn-type":[{"value":"2667-100X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatives to norepinephrine in septic shock: Which agents and when?","name":"articletitle","label":"Article Title"},{"value":"Journal of Intensive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jointm.2022.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}